Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,809	3,961	2,454	1,861	301	715
Market Cap Growth	95.72%	61.41%	31.88%	517.29%	-57.87%	6.05%
Enterprise Value	8,469	6,511	5,081	4,434	2,989	3,372
Last Close Price	18.19	12.60	7.92	6.07	1.99	4.79
PE Ratio	37.83	54.97	-	-	-	67.35
Forward PE	18.32	15.04	11.69	11.92	2.71	5.65
PS Ratio	1.86	1.31	0.88	0.78	0.14	0.34
PB Ratio	175.89	664.26	-55.10	30.35	1.44	1.86
P/FCF Ratio	69.90	16.43	10.45	6.23	18.49	3.75
P/OCF Ratio	28.93	11.65	8.32	5.38	4.63	2.96
PEG Ratio	-	0.51	0.51	0.51	0.18	0.66
EV/Sales Ratio	2.72	2.16	1.82	1.85	1.35	1.61
EV/EBITDA Ratio	12.28	10.11	8.69	9.05	6.79	7.49
EV/EBIT Ratio	17.10	15.48	14.59	17.03	14.94	15.57
EV/FCF Ratio	101.91	27.00	21.64	14.84	183.29	17.67
Debt / Equity Ratio	23.87	450.96	-58.22	44.87	13.62	7.52
Debt / EBITDA Ratio	3.94	4.06	4.31	5.43	6.15	6.15
Debt / FCF Ratio	33.59	11.15	11.05	9.21	174.50	15.13
Net Debt / Equity Ratio	22.74	402.92	-55.70	43.34	13.49	6.87
Net Debt / EBITDA Ratio	3.86	3.73	4.24	5.42	6.40	5.86
Net Debt / FCF Ratio	32.01	9.96	10.57	8.89	172.79	13.82
Asset Turnover	0.87	0.84	0.80	0.66	0.57	0.53
Inventory Turnover	2.92	3.10	2.98	2.77	2.79	2.67
Quick Ratio	1.38	1.39	0.82	0.87	1.10	1.39
Current Ratio	2.21	2.17	1.41	1.63	1.88	2.25
Return on Equity (ROE)	613.02%	-	-881.26%	-36.06%	-85.96%	5.45%
Return on Assets (ROA)	8.60%	7.32%	6.24%	4.48%	3.23%	3.41%
Return on Invested Capital (ROIC)	18.64%	16.18%	13.69%	9.07%	6.61%	4.62%
Return on Capital Employed (ROCE)	17.10%	15.00%	14.70%	9.90%	6.60%	6.60%
Earnings Yield	2.71%	1.82%	-4.76%	-4.51%	-43.12%	1.49%
FCF Yield	1.43%	6.09%	9.57%	16.06%	5.41%	26.68%
Buyback Yield / Dilution	-3.48%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%
Total Shareholder Return	-3.48%	-5.12%	-75.42%	-16.69%	0.58%	-1.95%

SEC Filings: 10-K · 10-Q